Seer to Report Second Quarter 2025 Financial Results on August 6, 2025
Rhea-AI Summary
Seer (Nasdaq: SEER), a company specializing in proteomic insights, has scheduled its Q2 2025 financial results announcement for August 6, 2025. The company will host a conference call and webcast at 1:30 PM PT / 4:30 PM ET on the same day.
Investors can access the live webcast through the Investor section at investor.seer.bio, where an archived replay will also be available after the event.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, SEER declined 1.40%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
REDWOOD CITY, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that it will report financial results for the second quarter 2025 on Wednesday, August 6, 2025. Company management will be webcasting a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Live audio of the webcast will be available on the Investor section of Seer’s website at investor.seer.bio. An archived replay will be available on the company’s website following the event.
About Seer
Seer, Inc. (Nasdaq: SEER) sets the standard in deep, unbiased proteomics—delivering insights with a scale, speed, precision, and reproducibility previously unattainable. Seer’s Proteograph Product Suite uniquely integrates proprietary engineered nanoparticles, streamlined automation instrumentation, optimized consumables, and advanced analytical software to solve challenges conventional methods have failed to overcome. Traditional proteomic technologies have struggled with inconsistent data, limited throughput, and prohibitive complexity, but Seer’s robust and scalable workflow consistently reveals biological insights that others cannot. Seer’s products are for research use only and are not intended for diagnostic procedures. For more information about Seer’s differentiated approach and ongoing leadership in proteomics, visit www.seer.bio.
Media Contact:
Consort Partners
pr@seer.bio
Investor Contact:
Carrie Mendivil
investor@seer.bio
FAQ
When will Seer (SEER) report Q2 2025 earnings?
What time is Seer's Q2 2025 earnings call?
How can I listen to Seer's Q2 2025 earnings call?
What does Seer company do?
